136 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
. The benefit from income taxes in the fourth quarter and the year of 2023 was primarily due to a pre-tax loss and our ability to carry back the R&D credit … to 2022. The benefit from income taxes in the fourth quarter of 2022 was primarily due to the Company’s pre-tax loss. The swing from a provision
S-3ASR
EX-4.6
xvcjt
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
ybgd2w996udfsebqi8r4
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.7
3yd 7uiw60wwv0b1em
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.8
q0gyqcpuazecz3qqv7u
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-1.2
ko6t21
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-4.5
wrq7jc7 5in
3 Nov 23
Automatic shelf registration
4:33pm
8-K
EX-99.1
y3qkvy8tcncjf
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
1c2 nsp89
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
lyvaxc
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm